These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 33113366)

  • 1. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity.
    Fuster JJ; Zuriaga MA; Zorita V; MacLauchlan S; Polackal MN; Viana-Huete V; Ferrer-Pérez A; Matesanz N; Herrero-Cervera A; Sano S; Cooper MA; González-Navarro H; Walsh K
    Cell Rep; 2020 Oct; 33(4):108326. PubMed ID: 33113366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
    Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
    J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis of Indeterminate Potential With Loss of
    Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL
    Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging drives Tet2+/- clonal hematopoiesis via IL-1 signaling.
    Caiado F; Kovtonyuk LV; Gonullu NG; Fullin J; Boettcher S; Manz MG
    Blood; 2023 Feb; 141(8):886-903. PubMed ID: 36379023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental TET2 Clonal Hematopoiesis Predisposes to Renal Hypertension Through an Inflammasome-Mediated Mechanism.
    Polizio AH; Marino L; Min KD; Yura Y; Rolauer L; Cochran JD; Evans MA; Park E; Doviak H; Miura-Yura E; Good ME; Wolpe AG; Grandoch M; Isakson BE; Walsh K
    Circ Res; 2024 Oct; 135(9):933-950. PubMed ID: 39234670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging.
    Jakobsen NA; Turkalj S; Zeng AGX; Stoilova B; Metzner M; Rahmig S; Nagree MS; Shah S; Moore R; Usukhbayar B; Angulo Salazar M; Gafencu GA; Kennedy A; Newman S; Kendrick BJL; Taylor AH; Afinowi-Luitz R; Gundle R; Watkins B; Wheway K; Beazley D; Murison A; Aguilar-Navarro AG; Flores-Figueroa E; Dakin SG; Carr AJ; Nerlov C; Dick JE; Xie SZ; Vyas P
    Cell Stem Cell; 2024 Aug; 31(8):1127-1144.e17. PubMed ID: 38917807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells.
    McClatchy J; Strogantsev R; Wolfe E; Lin HY; Mohammadhosseini M; Davis BA; Eden C; Goldman D; Fleming WH; Conley P; Wu G; Cimmino L; Mohammed H; Agarwal A
    Nat Commun; 2023 Dec; 14(1):8102. PubMed ID: 38062031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET2 mutation as prototypic clonal hematopoiesis lesion.
    Guarnera L; Jha BK
    Semin Hematol; 2024 Feb; 61(1):51-60. PubMed ID: 38431463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aging and clonal hematopoesis.].
    Bogdanov AN; Voloshin SV; Kunevich EO; Mikhaleva MA
    Adv Gerontol; 2024; 37(3):266-275. PubMed ID: 39139119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tet2-mediated clonal hematopoiesis in nonconditioned mice accelerates age-associated cardiac dysfunction.
    Wang Y; Sano S; Yura Y; Ke Z; Sano M; Oshima K; Ogawa H; Horitani K; Min KD; Miura-Yura E; Kour A; Evans MA; Zuriaga MA; Hirschi KK; Fuster JJ; Pietras EM; Walsh K
    JCI Insight; 2020 Mar; 5(6):. PubMed ID: 32154790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
    Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
    J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion.
    Quin C; DeJong EN; McNaughton AJM; Buttigieg MM; Basrai S; Abelson S; Larché MJ; Rauh MJ; Bowdish DME
    Blood Adv; 2024 Aug; 8(15):4169-4180. PubMed ID: 38924753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-induced inflammation exacerbates clonal hematopoiesis.
    Pasupuleti SK; Ramdas B; Burns SS; Palam LR; Kanumuri R; Kumar R; Pandhiri TR; Dave UP; Yellapu NK; Zhou X; Zhang C; Sandusky GE; Yu Z; Honigberg MC; Bick AG; Griffin GK; Niroula A; Ebert BL; Paczesny S; Natarajan P; Kapur R
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37071471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease.
    Cobo I; Tanaka T; Glass CK; Yeang C
    Curr Opin Hematol; 2022 Jan; 29(1):1-7. PubMed ID: 34654019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Disease, Aging, and Clonal Hematopoiesis.
    Evans MA; Sano S; Walsh K
    Annu Rev Pathol; 2020 Jan; 15():419-438. PubMed ID: 31689371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis and associated diseases: A review of recent findings.
    Asada S; Kitamura T
    Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease.
    Amorós-Pérez M; Fuster JJ
    Atherosclerosis; 2020 Mar; 297():120-126. PubMed ID: 32109665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.